Skip to main content
OpenTrials

Clinical trial condition

Epidermolysis Bullosa

Explore clinical trials studying Epidermolysis Bullosa. Study availability and eligibility vary by location and protocol.

58 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Epidermolysis Bullosa trial results

Completed

Allogeneic ABCB5-positive Stem Cells for Treatment of Epidermolysis Bullosa

NCT03529877

Conditions
Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • University of Minnesota, Masonic Cancer Center and Medical Center Minneapolis, Minnesota, United States
  • EB-Haus Austria; Salzburger Landeskliniken (SALK); Paracelsus Medizinische Privatuniversität Salzburg (PMU) Salzburg, Austria
  • Hôpital Saint-Louis; Département de dermatologie Paris, France
  • Department of Dermatology, Medical Center-University of Freiburg Freiburg im Breisgau, Germany
View Trial Details
Completed

Long Term Open-label Study Evaluating Safety of Diacerein 1% Ointment Topical Formulation in Subjects With Epidermolysis Bullosa Simplex

NCT03389308

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epidermolysis Bullosa, +7 more
Locations
  • Ann and Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • University of North Carolina (UNC) - Chapel Hill Chapel Hill, North Carolina, United States
  • Children's Hospital of San Antonio San Antonio, Texas, United States
View Trial Details
Completed

ESSENCE Study: Efficacy and Safety of SD-101 Cream in Participants With Epidermolysis Bullosa

NCT02384460

Conditions
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epidermolysis Bullosa, +6 more
Locations
  • Phoenix, Arizona, United States
  • Redwood City, California, United States
  • Aurora, Colorado, United States
  • Washington D.C., District of Columbia, United States
View all 38 locations
View Trial Details
Completed

To Evaluate the Pharmacokinetic of Diacerein and Rhein After Maximum Use in Patients With Epidermolysis Bullosa (EB)

NCT03472287

Conditions
Collagen Diseases, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Stanford School of Medicine Palo Alto, California, United States
  • Northwestern University Medical Center Chicago, Illinois, United States
  • UNC Dermatology Chapel Hill, North Carolina, United States
View Trial Details

Related conditions